Myopia
Conditions
Brief summary
To evaluate the efficacy and safety of 650nm low-level red-light irradiation for myopia control and prevention in children under less restrictive conditions than randomized controlled trials. Participants included children(aged 7 to 18 years, spherical equivalent error of 0.5D or below) who are already myopic at recruitment, and those who are of Emmetropia or low hyperopia.
Detailed description
This multicenter real world study will be conducted in at least 100 hospitals: Beijing Tongren Hospital will be the initiator of the study, other hospitals such as the Capital Institute of Pediatrics will serve as sub-centers. The whole study will last for three years.The investigators will perform data analysis at 6 months follow-up, one-year follow-up, and two-year follow-up. Participants who used 650 nm low-level red-light would be recruited. This kind of intervention will be integrated into a headworn device. This device could be used for treatment of myopia or amblyopia, and is safe for the eyes and has been verified by the Chinese market supervision and administration department.
Interventions
Typically, children who uses the 650 nm low-level red-light will be recruited into this study. The use of any other myopia intervention is not restricted except for low concentrations of atropine. Because atropine will cause pupils dilated, the amount of light entering the eye can not be controlled, and red-light is a laser, to be safe, we need to take certain consideration of the amount of light-entering. Participants receive the 650 nm low-level red-light intervention not because they are enrolled in a study, they would receive the intervention in the same manner and intensity if they were not enrolled in the study.
Sponsors
Beijing Tongren Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
7 Years to 18 Years
Healthy volunteers
Yes
Inclusion criteria
1. Children aged 7 to 18 years 2. The cycloplegic spherical equivalent error (SER) is +0.5D or less in both eyes 3. Astigmatism of 2.5 D or less (≤2.5D) 4. Willing to participate in the study and sign the informed consent form
Exclusion criteria
1. Including but not limited to the following eye diseases: strabismus, amblyopia, ocular tumors, glaucoma/macular disease and other fundus diseases (including heredity), keratitis, eye trauma, uveitis 2. Including but not limited to the following systemic diseases: epilepsy, tumor, heart disease, asthma, systemic immune diseases, infectious diseases 3. Mental diseases 4. Similar interventions have been used in the past year 5. Allergic to cycloplegic agents or to red light 6. The 650nm red light intervention was not suitable for the condition evaluated by the researchers 7. are currently using atropine or similar drugs, or have stopped using them for less than 1 month
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in spherical equivalent error | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Children's pupil were dilated using Mydrin-P eye drops, and then the refractive error was measured using an autorefractor. the two measurements (axial length and spherical equivalent error) will be aggregated to arrive at one reported value through the following way: axial enlongation will be defined as progress in myopia, decrease in spherical equivalent error will be defined as progress in myopia too. |
| Change in axial length | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Use an optical biometer to measure the axial length |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in steep keratometry | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Use an optical biometer to measure |
| Change in flat keratometry | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Use an optical biometer to measure |
| Change in anterior chamber depth | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Use an optical biometer to measure |
| Change in central corneal thickness | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Use an optical biometer to measure |
| Change in length thickness | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Use an optical biometer to measure |
| Change in Choroid thickness to measure | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Use an enhanced-depth imaging technique (based on Optical coherence tomography ) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Fundus injury related to 650 nm low-level red-light irridiationexamination | Baseline, six-month follow-up, one-year follow-up, two-year follow-up | Any potential fundus injury related to 650 nm low-level red-light irridiation would be checked through Fundus photography and coherence tomography examination |
Countries
China
Contacts
Primary ContactKai Cao
Outcome results
None listed